AARD — Aardvark Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual balance sheet for Aardvark Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K
Standards:	USG	USG	USG
Status:	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	16.1	9.99	73.7
Prepaid Expenses
Total Other Current Assets
Total Current Assets	16.5	10.4	74.1
Net Property, Plant And Equipment	0.252	0.155	0.735
Other Long Term Assets
Total Assets	16.8	10.5	77.5
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.595	1.38	4.93
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	0.776	1.43	5.39
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	16	9.1	72.1
Total Liabilities & Shareholders' Equity	16.8	10.5	77.5
Total Common Shares Outstanding
Total Preferred Shares Outstanding